Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
NGO · Belgium
Industry association · Germany
Declared costs: €100K+ a year · in the register since 2009
Medicinal products for human use · Standards of quality and safety for substances of human origin intended for human application
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
Time for Lyme ASBL · filed 25 Apr 2021 · source
About section B. Objectives and Policy options Ensure access to affordable medicines for patients, and address unmet medical needs; d) Consider the creation of specific incentives to promote the development of new classes of antimicrobials in combination with rules aiming to promote their prudent use and measures aligning use to patient needs, such as reduction of package sizes; Time for Lyme ASBL welcomes the…
Bundesverband der Pharmazeutischen Industrie e.V. · filed 27 Apr 2021 · source
The BPI e.V. (BPI) representing more than 270 members, comprises the whole spectrum of the pharmaceutical industry, ranging from multinational corporations to SMEs, Mid-Caps as well as Startups. These companies ensure a timely and safe supply of medicinal products for all patients across the EU and globally.
Bundesverband der Pharmazeutischen Industrie e.V. · filed 1 Nov 2023 · source
BPI welcomes the revision of the EU´s general pharmaceutical legislation and the Pharma Package (EU Pharmaceutical Legislative Revision) published by the European Commission on 26 April 2023. After more than 20 years, a revision of the existing provisions was necessary to ensure a legal framework that is adapted to the state of technology and research, while reducing bureaucracy to ensure that medicinal products can…
Bundesverband der Pharmazeutischen Industrie e.V. · filed 31 Aug 2022 · source
BPI welcomes the proposal for a Regulation on Substances of Human Origin (SoHO) presented by the European Commission on 14 July 2022 to replace the current EU legislation on blood, tissues and cells (BTC). The European Union needs a predictable, future-proof and resilient regulatory framework for SoHO.
Time for Lyme ASBL · filed 2 Sept 2022 · source
Time for Lyme ASBL welcomes the opportunity to give feedback about blood transfusion safety. Lyme disease (including Borreliosis), which is transmitted to humans by infected ticks, is the most common and increasing zoonosis in Europe.
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.